Role of the advanced glycation end products receptor in Crohn's disease inflammation

World Journal of Gastroenterology

Volumn 19, Issue 45, 2013, Pages 8269-8281

  Ciccocioppo, Rachele ^a   Vanoli, Alessandro ^a   Klersy, Catherine ^b   Imbesi, Venerina ^a   Boccaccio, Vincenzo ^a   Manca, Rachele ^a   Betti, Elena ^a   Cangemi, Giuseppina Cristina ^a   Strada, Elena ^b   Besio, Roberta ^a   Rossi, Antonio ^a   Falcone, Colomba ^a   Ardizzone, Sandro ^c   Fociani, Paolo ^c   Danelli, Piergiorgio ^c   Corazza, Gino Roberto ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Apoptosis; Chronic inflammation; Crohn's disease; Immunohistochemistry; Receptor for advanced glycation end products; Tumor necrosis factor

Indexed keywords

ADVANCED GLYCATION END PRODUCT; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATION; MALE; PROTEIN EXPRESSION; SCORING SYSTEM; UPREGULATION; WESTERN BLOTTING;

APOPTOSIS; CHRONIC INFLAMMATION; CROHN'S DISEASE; IMMUNOHISTOCHEMISTRY; RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS; TUMOR NECROSIS FACTOR-Α;

ADULT; AGED; APOPTOSIS; CASE-CONTROL STUDIES; CELLS, CULTURED; COLON; CROHN DISEASE; EPITHELIAL CELLS; FEMALE; HUMANS; ILEUM; INTESTINAL MUCOSA; MALE; MIDDLE AGED; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION; YOUNG ADULT;

EID: 84889581628     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i45.8269     Document Type: Article

References (40)

1. Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med 2009; 361: 2066-2078 [PMID: 19923578 DOI: 10.1056/ NEJMra0804647]
2. Ramasamy R, Yan SF, Schmidt AM. Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications. Ann N Y Acad Sci 2011; 1243: 88-102 [PMID: 22211895 DOI: 10.1111/j.1749-6632.2011.06320.x]
3. Hofmann Bowman MA, Schmidt AM. S100/calgranulins EN-RAGEing the blood vessels: implications for inflammatory responses and atherosclerosis. Am J Cardiovasc Dis 2011; 1: 92-100 [PMID: 22200033]
4. Srikanth V, Maczurek A, Phan T, Steele M, Westcott B, Juskiw D, Münch G. Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease. Neurobiol Aging 2011; 32: 763-777 [PMID: 19464758 DOI: 10.1016/j.neurobiola ging.2009.04.016]
5. Sims GP, Rowe DC, Rietdijk ST, Herbst R, Coyle AJ. HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol 2010; 28: 367-388 [PMID: 20192808 DOI: 10.1146/annurev. immunol.021908.132603]
6. Schmidt AM, Yan SD, Yan SF, Stern DM. The biology of the receptor for advanced glycation end products and its ligands. Biochim Biophys Acta 2000; 1498: 99-111 [PMID: 11108954 DOI: 10.1016/S0167-4889(00)00087-2]
7. Foell D, Wittkowski H, Vogl T, Roth J. S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J Leukoc Biol 2007; 81: 28-37 [PMID: 16943388 DOI: 10.1189/jlb.0306170]
8. Xie J, Reverdatto S, Frolov A, Hoffmann R, Burz DS, Shekhtman A. Structural basis for pattern recognition by the receptor for advanced glycation end products (RAGE). J Biol Chem 2008; 283: 27255-27269 [PMID: 18667420 DOI: 10.1074/jbc. M801622200]
9. Yeh CH, Sturgis L, Haidacher J, Zhang XN, Sherwood SJ, Bjercke RJ, Juhasz O, Crow MT, Tilton RG, Denner L. Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-kappaB transcriptional activation and cytokine secretion. Diabetes 2001; 50: 1495-1504 [PMID: 11375353 DOI: 10.2337/diabetes.50.6.1495]
10. Chavakis T, Bierhaus A, Al-Fakhri N, Schneider D, Witte S, Linn T, Nagashima M, Morser J, Arnold B, Preissner KT, Nawroth PP. The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. J Exp Med 2003; 198: 1507-1515 [PMID: 14623906 DOI: 10.1084/jem.20030800]
11. Zen K, Chen CX, Chen YT, Wilton R, Liu Y. Receptor for advanced glycation endproducts mediates neutrophil migration across intestinal epithelium. J Immunol 2007; 178: 2483-2490 [PMID: 17277156]
12. Foell D, Kucharzik T, Kraft M, Vogl T, Sorg C, Domschke W, Roth J. Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease. Gut 2003; 52: 847-853 [PMID: 12740341 DOI: 10.1136/gut.52.6.847]
13. Vitali R, Stronati L, Negroni A, Di Nardo G, Pierdomenico M, del Giudice E, Rossi P, Cucchiara S. Fecal HMGB1 is a novel marker of intestinal mucosal inflammation in pediatric inflammatory bowel disease. Am J Gastroenterol 2011; 106: 2029-2040 [PMID: 21788990 DOI: 10.1038/ajg.2011.231]
14. van Deventer SJ. Review article: targeting TNF alpha as a key cytokine in the inflammatory processes of Crohn's disease--the mechanisms of action of infliximab. Aliment Pharmacol Ther 1999; 13 Suppl 4: 3-8 [PMID: 10597333 DOI: 10.1046/ j.1365-2036.1999.00024.x]
15. Davé SH, Tilstra JS, Matsuoka K, Li F, DeMarco RA, Beer-Stolz D, Sepulveda AR, Fink MP, Lotze MT, Plevy SE. Ethyl pyruvate decreases HMGB1 release and ameliorates murine colitis. J Leukoc Biol 2009; 86: 633-643 [PMID: 19454652 DOI: 10.1189/jlb.1008662]
16. Santaolalla R, Mañé J, Pedrosa E, Lorén V, Fernández-Bañares F, Mallolas J, Carrasco A, Salas A, Rosinach M, Forné M, Espinós JC, Loras C, Donovan M, Puig P, Mañosa M, Gassull MA, Viver JM, Esteve M. Apoptosis resistance of mucosal lymphocytes and IL-10 deficiency in patients with steroid-refractory Crohn's disease. Inflamm Bowel Dis 2011; 17: 1490-1500 [PMID: 21674705 DOI: 10.1002/ibd.21507]
17. Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006; 55: 749-753 [PMID: 16698746 DOI: 10.1136/gut.2005.082909]
18. Best WR, Becktel JM, Singleton JW, Kern F. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976; 70: 439-444 [PMID: 1248701]
19. Van Assche G, Dignass A, Panes J, Beaugerie L, Karagiannis J, Allez M, Ochsenkühn T, Orchard T, Rogler G, Louis E, Kupcinskas L, Mantzaris G, Travis S, Stange E. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis. J Crohns Colitis 2010; 4: 7-27 [PMID: 21122488 DOI: 10.1016/ j.crohns.2009.12.003]
20. Sasahira T, Akama Y, Fujii K, Kuniyasu H. Expression of receptor for advanced glycation end products and HMGB1/ amphoterin in colorectal adenomas. Virchows Arch 2005; 446: 411-415 [PMID: 15789216 DOI: 10.1007/s00428-005-1210-x]
21. Morbini P, Villa C, Campo I, Zorzetto M, Inghilleri S, Luisetti M. The receptor for advanced glycation end products and its ligands: a new inflammatory pathway in lung disease? Mod Pathol 2006; 19: 1437-1445 [PMID: 16941014]
22. Landesberg R, Woo V, Huang L, Cozin M, Lu Y, Bailey C, Qu W, Pulse C, Schmidt AM. The expression of the receptor for glycation endproducts (RAGE) in oral squamous cell carcinomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008; 105: 617-624 [PMID: 18206396 DOI: 10.1016/ j.tripleo.2007.08.006]
23. Katz J, Bhattacharyya I, Farkhondeh-Kish F, Perez FM, Caudle RM, Heft MW. Expression of the receptor of advanced glycation end products in gingival tissues of type 2 diabetes patients with chronic periodontal disease: a study utilizing immunohistochemistry and RT-PCR. J Clin Periodontol 2005; 32: 40-44 [PMID: 15642057 DOI: 10.1111/j.1600-051X.2004.00623.x]
24. Grimes CL, Ariyananda Lde Z, Melnyk JE, O'Shea EK. The innate immune protein Nod2 binds directly to MDP, a bacterial cell wall fragment. J Am Chem Soc 2012; 134: 13535-13537 [PMID: 22857257 DOI: 10.1021/ja303883c]
25. Schmidt AM, Hori O, Cao R, Yan SD, Brett J, Wautier JL, Ogawa S, Kuwabara K, Matsumoto M, Stern D. RAGE: a novel cellular receptor for advanced glycation end products. Diabetes 1996; 45 Suppl 3: S77-S80 [PMID: 8674899]
26. Schmidt AM, Yan SD, Yan SF, Stern DM. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest 2001; 108: 949-955 [PMID: 11581294]
27. Sunahori K, Yamamura M, Yamana J, Takasugi K, Kawashima M, Makino H. Increased expression of receptor for advanced glycation end products by synovial tissue macrophages in rheumatoid arthritis. Arthritis Rheum 2006; 54: 97-104 [PMID: 16385501 DOI: 10.1002/art.21524]
28. Abdulahad DA, Westra J, Limburg PC, Kallenberg CG, Bijl M. HMGB1 in systemic lupus Erythematosus: Its role in cutaneous lesions development. Autoimmun Rev 2010; 9: 661-665 [PMID: 20546955 DOI: 10.1016/j.autrev.2010.05.015]
29. Sternberg Z, Ostrow P, Vaughan M, Chichelli T, Munschauer F. AGE-RAGE in multiple sclerosis brain. Immunol Invest 2011; 40: 197-205 [PMID: 21080832 DOI: 10.3109/08820139.20 10.532267]
30. Rojas A, González I, Rodríguez B, Romero J, Figueroa H, Llanos J, Morales E, Pérez-Castro R. Evidence of involvement of the receptor for advanced glycation end-products (RAGE) in the adhesion of Helicobacter pylori to gastric epithelial cells. Microbes Infect 2011; 13: 818-823 [PMID: 21609778 DOI: 10.1016/j.micinf.2011.04.005]
31. Däbritz J, Friedrichs F, Weinhage T, Hampe J, Kucharzik T, Lügering A, Broeckel U, Schreiber S, Spieker T, Stoll M, Foell D. The functional-374T/A polymorphism of the receptor for advanced glycation end products may modulate Crohn' s disease. Am J Physiol Gastrointest Liver Physiol 2011; 300: G823-G832 [PMID: 21311028 DOI: 10.1152/ajpgi.00115.2010]
32. Cheng C, Tsuneyama K, Kominami R, Shinohara H, Sakurai S, Yonekura H, Watanabe T, Takano Y, Yamamoto H, Yamamoto Y. Expression profiling of endogenous secretory receptor for advanced glycation end products in human organs. Mod Pathol 2005; 18: 1385-1396 [PMID: 15933755 DOI: 10.1038/modpathol.3800450]
33. Zen K, Chen CX, Chen YT, Wilton R, Liu Y. Receptor for advanced glycation endproducts mediates neutrophil migration across intestinal epithelium. J Immunol 2007; 178: 2483-2490 [PMID: 17277156]
34. Kang R, Tang D, Lotze MT, Zeh HJ. RAGE regulates autophagy and apoptosis following oxidative injury. Autophagy 2011; 7: 442-444 [PMID: 21317562 DOI: 10.4161/auto.7.4.14681]
35. Chen Y, Akirav EM, Chen W, Henegariu O, Moser B, Desai D, Shen JM, Webster JC, Andrews RC, Mjalli AM, Rothlein R, Schmidt AM, Clynes R, Herold KC. RAGE ligation affects T cell activation and controls T cell differentiation. J Immunol 2008; 181: 4272-4278 [PMID: 18768885]
36. Fritz T, Niederreiter L, Adolph T, Blumberg RS, Kaser A. Crohn's disease: NOD2, autophagy and ER stress converge. Gut 2011; 60: 1580-1588 [PMID: 21252204 DOI: 10.1136/ gut.2009.206466]
37. Strober W, Fuss IJ. Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology 2011; 140: 1756-1767 [PMID: 21530742 DOI: 10.1053/ j.gastro.2011.02.016]
38. Kosovac K, Brenmoehl J, Holler E, Falk W, Schoelmerich J, Hausmann M, Rogler G. Association of the NOD2 genotype with bacterial translocation via altered cell-cell contacts in Crohn's disease patients. Inflamm Bowel Dis 2010; 16: 1311-1321 [PMID: 20232407 DOI: 10.1002/ibd.21223]
39. Sparvero LJ, Asafu-Adjei D, Kang R, Tang D, Amin N, Im J, Rutledge R, Lin B, Amoscato AA, Zeh HJ, Lotze MT. RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation. J Transl Med 2009; 7: 17 [PMID: 19292913]
40. Norata GD, Garlaschelli K, Grigore L, Tibolla G, Raselli S, Redaelli L, Buccianti G, Catapano AL. Circulating soluble receptor for advanced glycation end products is inversely associated with body mass index and waist/hip ratio in the general population. Nutr Metab Cardiovasc Dis 2009; 19: 129-134 [PMID: 18595673 DOI: 10.1016/j.numecd.2008.03.004]